Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome

NCT00157274 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Mycosis Fungoides
Sezary Syndrome

Interventions

DRUG: alemtuzumab

Sponsor

Latin American Cooperative Onco-Haematology Group - Peru